Natco Pharma is currently trading at Rs. 968.20, up by 13.70 points or 1.44% from its previous closing of Rs. 954.50 on the BSE.
The scrip opened at Rs. 958.70 and has touched a high and low of Rs. 977.00 and Rs. 958.70 respectively. So far 20996 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1015.00 on 18-Apr-2017 and a 52 week low of Rs. 480.00 on 03-Jun-2016.
Last one week high and low of the scrip stood at Rs. 977.00 and Rs. 875.00 respectively. The current market cap of the company is Rs. 16865.15 crore.
The promoters holding in the company stood at 51.24%, while institutions and non-institutions held 26.70% and 22.05% respectively.
In a bid to achieve 20% growth year-on-year, Natco Pharma is planning to launch around 8-10 new products in domestic branded formulations segment during FY18. The Hyderabad-based drug firm is also planning to maintain its leadership position in oncology and gastro hepatology segment during the year as part of its short-term growth plan.
Moreover, the company is looking at gaining traction in the newly launched cardiology and diabetology (CnD) division. The company is also planning to expand its Hepatitis-C product portfolio during the year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: